1. Home
  2. TRT vs INO Comparison

TRT vs INO Comparison

Compare TRT & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trio-Tech International

TRT

Trio-Tech International

N/A

Current Price

$10.39

Market Cap

109.1M

Sector

Technology

ML Signal

N/A

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

N/A

Current Price

$1.27

Market Cap

100.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRT
INO
Founded
1958
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.1M
100.4M
IPO Year
1995
1999

Fundamental Metrics

Financial Performance
Metric
TRT
INO
Price
$10.39
$1.27
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
245.9K
6.2M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.18
EPS
0.02
N/A
Revenue
$32,462,000.00
$42,220,086.00
Revenue This Year
N/A
$20,156.19
Revenue Next Year
N/A
$421.95
P/E Ratio
$504.50
N/A
Revenue Growth
N/A
19.37
52 Week Low
$4.42
$0.56
52 Week High
$21.38
$2.86

Technical Indicators

Market Signals
Indicator
TRT
INO
Relative Strength Index (RSI) 44.39 66.01
Support Level $9.15 $1.03
Resistance Level $12.01 $1.79
Average True Range (ATR) 0.70 0.10
MACD -0.08 0.06
Stochastic Oscillator 10.44 94.23

Price Performance

Historical Comparison
TRT
INO

About TRT Trio-Tech International

Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: